SynthesisFrontiers in immunology2023

Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis.

Xiaosheng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.